Answers are grounded in this paper and cite their sources.
Our experiments established CD36 as a key mediator of FA-induced metastasis of GC via the AKT/GSK-3β/β-catenin signaling pathway. CD36 might, therefore, constitute a potential therapeutic target for clinical intervention in GC.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: